Jane Alexander, at 47, was diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD). The diagnosis came as a surprise, as she believed her occasional wine consumption was not excessive.
MASLD is a condition characterized by fat accumulation in the liver, often triggered by lifestyle factors such as being overweight, Type 2 diabetes, poor diet, high cholesterol, and lack of physical activity. Approximately one in four people in the U.S. are estimated to have MASLD. While alcohol can exacerbate liver issues, MASLD is primarily linked to metabolic and lifestyle factors. A combined condition, MetALD, involves both metabolic dysfunction and alcohol consumption.
Experts note that liver disease often progresses silently, with early stages showing no obvious symptoms. Fatigue and discomfort in the upper right abdomen can sometimes occur, but these symptoms are often overlooked or attributed to other causes, particularly in busy individuals. Mortality rates associated with liver disease have increased significantly over the past 50 years, with MASLD cases rising substantially since 1990. Worryingly, an estimated one in ten children exhibit early signs of the disease. Preventable factors like alcohol consumption, obesity, and unhealthy diets are linked to a high percentage of liver-related deaths.
Stigma surrounding liver disease can deter individuals from seeking medical advice, with many fearing judgment about their lifestyle choices. However, Alexander’s diagnosis prompted a significant shift in her habits. She abstained from alcohol for over a year, lost 42 pounds, and incorporated exercise into her routine.
Despite these changes, genetic high cholesterol and a significant sugar intake continued to affect her liver health. Research indicates a strong connection between excessive sugar consumption and MASLD, as it can lead to insulin resistance and promote fat accumulation in the liver. To address her sugar cravings, Alexander participated in a “sugar detox” program, which aimed to break her habit, reset her taste buds, and improve her liver health. The program involved a significant reduction in sugar intake, followed by a structured reintroduction. While challenging initially, the enforced habit change and subsequent at-home program helped her manage cravings.
Alexander’s latest medical tests show her liver is now healthy. Currently, there are no approved drug therapies specifically for MASLD, although clinical trials are ongoing. Some emerging treatments, like GLP-1 agonists (e.g., Ozempic), are being investigated for their potential to reduce liver fat and aid weight loss. However, experts emphasize that prevention and lifestyle changes remain the most effective tools for managing and reversing the condition. Alexander now advocates for proactive liver health and encourages regular check-ups, stating that her diagnosis, initially shameful, ultimately led to positive and life-altering changes.